MiRNA-based Regenerative therapy for T2D: MiRNA-125b promotes reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 6/September/2014, 10.04 am

Molecular therapy for Human Cancer: 17α-E2 (an estrogen derivative) increases the expression of tumor suppressor ARF via down regulation of its target gene, 6/September/2014, 05.53 am
September 6, 2014
Natural product-based therapy for Bone disorders: Cirsilol (3′,4′,5-trihydroxy-6,7-dimethoxyflavone), a flavone isolated from Achillea fragrantissima, inhibits osteoporosis and bone metastasis via up regulation of its target gene, 6/September/2014, 10.13 am
September 6, 2014
Show all

A recent study from the Mammalian Genetics Laboratory, Cancer Research UK London Research Institute, Lincoln’s Inn Fields Laboratories, London, United Kingdom; and School of Medicine, King’s College London, London, United Kingdom shows that “Loss of Fbw7 Reprograms Adult Pancreatic Ductal Cells into α, δ, and β Cells.” This study was published in the August 7  2014 Cell Stem Cell (Number1 journal in Regenerative Medicine wiht an I.F of ~25) by Prof Axel Behrens, Rocio Sancho, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that: MiRNA-based Regenerative therapy for T2D: MiRNA-125b promotes  reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3. This study suggests that MiRNA-125bby increasing the expression of Ngn3 in adult pancreatic ductal cells, it may reprogram adult pancreatic ductal cells into β cells.  Thereby, it may induce the expression of Ngn3increase insulin secretion and inhibit insulin resistance. Together, this study suggests that pharmacological formulations encompassingMiRNA-125b activators” may be used to regenerate  β cells in T2D patients. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based Regenerative therapy for T2D: MiRNA-125b promotes  reprogramming of adult pancreatic ductal cells into α, δ, and β cells via up regulation of Ngn3, 6/September/2014, 10.04 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.